Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 274 entries
Sorted by: Best Match Show Resources per page
DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients.

Scientific reports

Mathe A, Wong-Brown M, Locke WJ, Stirzaker C, Braye SG, Forbes JF, Clark SJ, Avery-Kiejda KA, Scott RJ.
PMID: 27671774
Sci Rep. 2016 Sep 27;6:33435. doi: 10.1038/srep33435.

Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype with no targeted treatment available. Our previous study identified 38 TNBC-specific genes with altered expression comparing tumour to normal samples. This study aimed to establish whether DNA...

Cite
Mathe A, Wong-Brown M, Locke WJ, et al. DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients. Sci Rep. 2016;6:33435doi: 10.1038/srep33435.
Mathe, A., Wong-Brown, M., Locke, W. J., Stirzaker, C., Braye, S. G., Forbes, J. F., Clark, S. J., Avery-Kiejda, K. A., & Scott, R. J. (2016). DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients. Scientific reports, 633435. https://doi.org/10.1038/srep33435
Mathe, Andrea, et al. "DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients." Scientific reports vol. 6 (2016): 33435. doi: https://doi.org/10.1038/srep33435
Mathe A, Wong-Brown M, Locke WJ, Stirzaker C, Braye SG, Forbes JF, Clark SJ, Avery-Kiejda KA, Scott RJ. DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients. Sci Rep. 2016 Sep 27;6:33435. doi: 10.1038/srep33435. PMID: 27671774; PMCID: PMC5037364.
Copy Download .nbib Format: NLM
Expression of renin-angiotensin system (RAS) components in endometrial cancer.

Endocrine connections

Delforce SJ, Lumbers ER, Corbisier de Meaultsart C, Wang Y, Proietto A, Otton G, Scurry J, Verrills NM, Scott RJ, Pringle KG.
PMID: 27956412
Endocr Connect. 2017 Jan;6(1):9-19. doi: 10.1530/EC-16-0082. Epub 2016 Dec 12.

A dysfunctional endometrial renin-angiotensin system (RAS) could aid the growth and spread of endometrial cancer. To determine if the RAS is altered in endometrial cancer, we measured RAS gene expression and protein levels in 30 human formalin-fixed, paraffin-embedded (FFPE)...

Cite
Delforce SJ, Lumbers ER, Corbisier de Meaultsart C, et al. Expression of renin-angiotensin system (RAS) components in endometrial cancer. Endocr Connect. 2016;6(1):9-19doi: 10.1530/EC-16-0082.
Delforce, S. J., Lumbers, E. R., Corbisier de Meaultsart, C., Wang, Y., Proietto, A., Otton, G., Scurry, J., Verrills, N. M., Scott, R. J., & Pringle, K. G. (2017). Expression of renin-angiotensin system (RAS) components in endometrial cancer. Endocrine connections, 6(1), 9-19. https://doi.org/10.1530/EC-16-0082
Delforce, Sarah J, et al. "Expression of renin-angiotensin system (RAS) components in endometrial cancer." Endocrine connections vol. 6,1 (2017): 9-19. doi: https://doi.org/10.1530/EC-16-0082
Delforce SJ, Lumbers ER, Corbisier de Meaultsart C, Wang Y, Proietto A, Otton G, Scurry J, Verrills NM, Scott RJ, Pringle KG. Expression of renin-angiotensin system (RAS) components in endometrial cancer. Endocr Connect. 2017 Jan;6(1):9-19. doi: 10.1530/EC-16-0082. Epub 2016 Dec 12. PMID: 27956412; PMCID: PMC5302162.
Copy Download .nbib Format: NLM
The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance.

Frontiers in cardiovascular medicine

Gourraud JB, Barc J, Thollet A, Le Scouarnec S, Le Marec H, Schott JJ, Redon R, Probst V.
PMID: 27200363
Front Cardiovasc Med. 2016 Apr 25;3:9. doi: 10.3389/fcvm.2016.00009. eCollection 2016.

For the last 10 years, applying new sequencing technologies to thousands of whole exomes has revealed the high variability of the human genome. Extreme caution should thus be taken to avoid misinterpretation when associating rare genetic variants to disease...

Cite
Gourraud JB, Barc J, Thollet A, et al. The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance. Front Cardiovasc Med. 2016;3:9doi: 10.3389/fcvm.2016.00009.
Gourraud, J. B., Barc, J., Thollet, A., Le Scouarnec, S., Le Marec, H., Schott, J. J., Redon, R., & Probst, V. (2016). The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance. Frontiers in cardiovascular medicine, 39. https://doi.org/10.3389/fcvm.2016.00009
Gourraud, Jean-Baptiste, et al. "The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance." Frontiers in cardiovascular medicine vol. 3 (2016): 9. doi: https://doi.org/10.3389/fcvm.2016.00009
Gourraud JB, Barc J, Thollet A, Le Scouarnec S, Le Marec H, Schott JJ, Redon R, Probst V. The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance. Front Cardiovasc Med. 2016 Apr 25;3:9. doi: 10.3389/fcvm.2016.00009. eCollection 2016. PMID: 27200363; PMCID: PMC4842929.
Copy Download .nbib Format: NLM
School Maladjustments of Some Mentally Superior Patients in a Psychiatric Clinic.

The Psychological clinic

Schott EL.
PMID: 28909598
Psychol Clin. 1932 Sep-Nov;21(3):202-207.

No abstract available.

Cite
Schott EL. School Maladjustments of Some Mentally Superior Patients in a Psychiatric Clinic. Psychol Clin. 1932;21(3):202-207
Schott, E. L. (1932). School Maladjustments of Some Mentally Superior Patients in a Psychiatric Clinic. The Psychological clinic, 21(3), 202-207.
Schott, E L. "School Maladjustments of Some Mentally Superior Patients in a Psychiatric Clinic." The Psychological clinic vol. 21,3 (1932): 202-207.
Schott EL. School Maladjustments of Some Mentally Superior Patients in a Psychiatric Clinic. Psychol Clin. 1932 Sep-Nov;21(3):202-207. PMID: 28909598; PMCID: PMC5142686.
Copy Download .nbib Format: NLM
Is hemochromatosis a risk factor for Alzheimer's disease?.

Journal of Alzheimer's disease : JAD

Connor JR, Milward EA, Moalem S, Sampietro M, Boyer P, Percy ME, Vergani C, Scott RJ, Chorney M.
PMID: 12214033
J Alzheimers Dis. 2001 Oct;3(5):471-477. doi: 10.3233/jad-2001-3506.

Excess iron accumulation in the brain is a consistent observation in Alzheimer's Disease. Iron affects amyloid precursor protein (AbetaPP) processing and promotes deposition of Abeta. Iron is also among the most potent biological toxins because of its ability to...

Cite
Connor JR, Milward EA, Moalem S, et al. Is hemochromatosis a risk factor for Alzheimer's disease?. J Alzheimers Dis. 2001;3(5):471-477doi: 10.3233/jad-2001-3506.
Connor, J. R., Milward, E. A., Moalem, S., Sampietro, M., Boyer, P., Percy, M. E., Vergani, C., Scott, R. J., & Chorney, M. (2001). Is hemochromatosis a risk factor for Alzheimer's disease?. Journal of Alzheimer's disease : JAD, 3(5), 471-477. https://doi.org/10.3233/jad-2001-3506
Connor, J.R., et al. "Is hemochromatosis a risk factor for Alzheimer's disease?." Journal of Alzheimer's disease : JAD vol. 3,5 (2001): 471-477. doi: https://doi.org/10.3233/jad-2001-3506
Connor JR, Milward EA, Moalem S, Sampietro M, Boyer P, Percy ME, Vergani C, Scott RJ, Chorney M. Is hemochromatosis a risk factor for Alzheimer's disease?. J Alzheimers Dis. 2001 Oct;3(5):471-477. doi: 10.3233/jad-2001-3506. PMID: 12214033.
Copy Download .nbib Format: NLM
The Inheritance of Resistance to SALMONELLA AERTRYCKE in Various Strains of Mice.

Genetics

Schott RG.
PMID: 17246651
Genetics. 1932 Mar;17(2):203-29. doi: 10.1093/genetics/17.2.203.

No abstract available.

Cite
Schott RG. The Inheritance of Resistance to SALMONELLA AERTRYCKE in Various Strains of Mice. Genetics. 1932;17(2):203-29doi: 10.1093/genetics/17.2.203.
Schott, R. G. (1932). The Inheritance of Resistance to SALMONELLA AERTRYCKE in Various Strains of Mice. Genetics, 17(2), 203-29. https://doi.org/10.1093/genetics/17.2.203
Schott, R G. "The Inheritance of Resistance to SALMONELLA AERTRYCKE in Various Strains of Mice." Genetics vol. 17,2 (1932): 203-29. doi: https://doi.org/10.1093/genetics/17.2.203
Schott RG. The Inheritance of Resistance to SALMONELLA AERTRYCKE in Various Strains of Mice. Genetics. 1932 Mar;17(2):203-29. doi: 10.1093/genetics/17.2.203. PMID: 17246651; PMCID: PMC1201657.
Copy Download .nbib Format: NLM
Removal of pentachlorophenol from aqueous solutions by dolomitic sorbents.

Journal of colloid and interface science

Marouf R, Khelifa N, Marouf-Khelifa K, Schott J, Khelifa A.
PMID: 16376921
J Colloid Interface Sci. 2006 May 01;297(1):45-53. doi: 10.1016/j.jcis.2005.10.030. Epub 2005 Dec 27.

The partial decomposition of dolomite carried out within the temperature range 600-1000 degrees C provides new sorbents, called dolomitic sorbents. Their surface properties and identification by X-ray diffraction are discussed. The lowest specific surface area value was found for...

Cite
Marouf R, Khelifa N, Marouf-Khelifa K, et al. Removal of pentachlorophenol from aqueous solutions by dolomitic sorbents. J Colloid Interface Sci. 2005;297(1):45-53doi: 10.1016/j.jcis.2005.10.030.
Marouf, R., Khelifa, N., Marouf-Khelifa, K., Schott, J., & Khelifa, A. (2006). Removal of pentachlorophenol from aqueous solutions by dolomitic sorbents. Journal of colloid and interface science, 297(1), 45-53. https://doi.org/10.1016/j.jcis.2005.10.030
Marouf, Reda, et al. "Removal of pentachlorophenol from aqueous solutions by dolomitic sorbents." Journal of colloid and interface science vol. 297,1 (2006): 45-53. doi: https://doi.org/10.1016/j.jcis.2005.10.030
Marouf R, Khelifa N, Marouf-Khelifa K, Schott J, Khelifa A. Removal of pentachlorophenol from aqueous solutions by dolomitic sorbents. J Colloid Interface Sci. 2006 May 01;297(1):45-53. doi: 10.1016/j.jcis.2005.10.030. Epub 2005 Dec 27. PMID: 16376921.
Copy Download .nbib Format: NLM
Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany.

Clinical drug investigation

Klimek L, Wrede H, Schott BC, Hansen I.
PMID: 17532705
Clin Drug Investig. 2005;25(9):609-14. doi: 10.2165/00044011-200525090-00006.

No abstract available.

Cite
Klimek L, Wrede H, Schott BC, et al. Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany. Clin Drug Investig. 2005;25(9):609-14doi: 10.2165/00044011-200525090-00006.
Klimek, L., Wrede, H., Schott, B. C., & Hansen, I. (2005). Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany. Clinical drug investigation, 25(9), 609-14. https://doi.org/10.2165/00044011-200525090-00006
Klimek, L, et al. "Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany." Clinical drug investigation vol. 25,9 (2005): 609-14. doi: https://doi.org/10.2165/00044011-200525090-00006
Klimek L, Wrede H, Schott BC, Hansen I. Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany. Clin Drug Investig. 2005;25(9):609-14. doi: 10.2165/00044011-200525090-00006. PMID: 17532705.
Copy Download .nbib Format: NLM
Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.

Hereditary cancer in clinical practice

Bowden NA, Croft A, Scott RJ.
PMID: 19725988
Hered Cancer Clin Pract. 2007 Jun 15;5(2):79-96. doi: 10.1186/1897-4287-5-2-79.

Gene expression profiling is a powerful method by which alterations in gene expression can be interrogated in a single experiment. The disease familial adenomatous polyposis (FAP) is associated with germline mutations in the APC gene, which result in aberrant...

Cite
Bowden NA, Croft A, Scott RJ. Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease. Hered Cancer Clin Pract. 2007;5(2):79-96doi: 10.1186/1897-4287-5-2-79.
Bowden, N. A., Croft, A., & Scott, R. J. (2007). Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease. Hereditary cancer in clinical practice, 5(2), 79-96. https://doi.org/10.1186/1897-4287-5-2-79
Bowden, Nikola A, et al. "Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease." Hereditary cancer in clinical practice vol. 5,2 (2007): 79-96. doi: https://doi.org/10.1186/1897-4287-5-2-79
Bowden NA, Croft A, Scott RJ. Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease. Hered Cancer Clin Pract. 2007 Jun 15;5(2):79-96. doi: 10.1186/1897-4287-5-2-79. PMID: 19725988; PMCID: PMC2736996.
Copy Download .nbib Format: NLM
Familial breast and bowel cancer: does it exist?.

Hereditary cancer in clinical practice

Scott RJ, Ashton KA.
PMID: 20233481
Hered Cancer Clin Pract. 2004 Feb 15;2(1):25-9. doi: 10.1186/1897-4287-2-1-25.

There is much debate in the literature about familial predispositions to breast and bowel cancers yet little evidence is forthcoming to suggest that there are susceptibility genes that can account for such kindreds. Within the context of known susceptibility...

Cite
Scott RJ, Ashton KA. Familial breast and bowel cancer: does it exist?. Hered Cancer Clin Pract. 2004;2(1):25-9doi: 10.1186/1897-4287-2-1-25.
Scott, R. J., & Ashton, K. A. (2004). Familial breast and bowel cancer: does it exist?. Hereditary cancer in clinical practice, 2(1), 25-9. https://doi.org/10.1186/1897-4287-2-1-25
Scott, Rodney J, and Ashton, Katie A. "Familial breast and bowel cancer: does it exist?." Hereditary cancer in clinical practice vol. 2,1 (2004): 25-9. doi: https://doi.org/10.1186/1897-4287-2-1-25
Scott RJ, Ashton KA. Familial breast and bowel cancer: does it exist?. Hered Cancer Clin Pract. 2004 Feb 15;2(1):25-9. doi: 10.1186/1897-4287-2-1-25. PMID: 20233481; PMCID: PMC2839991.
Copy Download .nbib Format: NLM
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Hereditary cancer in clinical practice

Talseth-Palmer BA, McPhillips M, Groombridge C, Spigelman A, Scott RJ.
PMID: 20487569
Hered Cancer Clin Pract. 2010 May 21;8(1):5. doi: 10.1186/1897-4287-8-5.

BACKGROUND: Approximately 10% of Lynch syndrome families have a mutation in MSH6 and fewer families have a mutation in PMS2. It is assumed that the cancer incidence is the same in families with mutations in MSH6 as in families...

Cite
Talseth-Palmer BA, McPhillips M, Groombridge C, et al. MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hered Cancer Clin Pract. 2010;8(1):5doi: 10.1186/1897-4287-8-5.
Talseth-Palmer, B. A., McPhillips, M., Groombridge, C., Spigelman, A., & Scott, R. J. (2010). MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hereditary cancer in clinical practice, 8(1), 5. https://doi.org/10.1186/1897-4287-8-5
Talseth-Palmer, Bente A, et al. "MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer." Hereditary cancer in clinical practice vol. 8,1 (2010): 5. doi: https://doi.org/10.1186/1897-4287-8-5
Talseth-Palmer BA, McPhillips M, Groombridge C, Spigelman A, Scott RJ. MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer. Hered Cancer Clin Pract. 2010 May 21;8(1):5. doi: 10.1186/1897-4287-8-5. PMID: 20487569; PMCID: PMC2890527.
Copy Download .nbib Format: NLM
Gene expression profiling of xeroderma pigmentosum.

Hereditary cancer in clinical practice

Bowden NA, Tooney PA, Scott RJ.
PMID: 20223010
Hered Cancer Clin Pract. 2006 May 15;4(2):103-10. doi: 10.1186/1897-4287-4-2-103.

Xeroderma pigmentosum (XP) is a rare recessive disorder that is characterized by extreme sensitivity to UV light. UV light exposure results in the formation of DNA damage such as cyclobutane dimers and (6-4) photoproducts. Nucleotide excision repair (NER) orchestrates...

Cite
Bowden NA, Tooney PA, Scott RJ. Gene expression profiling of xeroderma pigmentosum. Hered Cancer Clin Pract. 2006;4(2):103-10doi: 10.1186/1897-4287-4-2-103.
Bowden, N. A., Tooney, P. A., & Scott, R. J. (2006). Gene expression profiling of xeroderma pigmentosum. Hereditary cancer in clinical practice, 4(2), 103-10. https://doi.org/10.1186/1897-4287-4-2-103
Bowden, Nikola A, et al. "Gene expression profiling of xeroderma pigmentosum." Hereditary cancer in clinical practice vol. 4,2 (2006): 103-10. doi: https://doi.org/10.1186/1897-4287-4-2-103
Bowden NA, Tooney PA, Scott RJ. Gene expression profiling of xeroderma pigmentosum. Hered Cancer Clin Pract. 2006 May 15;4(2):103-10. doi: 10.1186/1897-4287-4-2-103. PMID: 20223010; PMCID: PMC2837287.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 274 entries